D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$384M |
| 2 |
Apple
AAPL
|
+$377M |
| 3 |
PayPal
PYPL
|
+$368M |
| 4 |
Pfizer
PFE
|
+$339M |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.02B |
| 2 |
XLNX
Xilinx Inc
XLNX
|
+$732M |
| 3 |
Netflix
NFLX
|
+$461M |
| 4 |
Citigroup
C
|
+$361M |
| 5 |
Booking.com
BKNG
|
+$288M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.52% |
| 2 | Consumer Discretionary | 9.06% |
| 3 | Financials | 8.14% |
| 4 | Healthcare | 8% |
| 5 | Energy | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3276
PUT
FuboTV Inc
FUBO
$260M
| $1.74M | ﹤0.01% |
22,083
-417
| -2% | -$48.7K |
|
|
BOCN
3277
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
| $1.74M | ﹤0.01% |
+175,810
| New | +$1.73M |
|
|
TETEU
3278
DELISTED
Technology & Telecommunication Acquisition Corporation Unit
TETEU
| $1.74M | ﹤0.01% |
+172,175
| New | +$1.73M |
|
|
CMRC
3279
PUT
Commerce.com Inc Series 1
CMRC
$272M
| $1.74M | ﹤0.01% |
79,200
+34,200
| +76% | +$918K |
|
|
PGRE
3280
DELISTED
Paramount Group
PGRE
| $1.73M | ﹤0.01% |
158,930
+16,776
| +12% | +$164K |
|
3281
RadNet
RDNT
$4.98B
| $1.73M | ﹤0.01% |
+77,520
| New | +$1.9M |
|
3282
PUT
Quaker Houghton
KWR
$2.58B
| $1.73M | ﹤0.01% |
+10,000
| New | +$1.99M |
|
3283
PUT
Yeti Holdings
YETI
$3.87B
| $1.73M | ﹤0.01% |
+28,800
| New | +$1.86M |
|
|
AMTI
3284
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $1.73M | ﹤0.01% |
229,640
+119,816
| +109% | +$992K |
|
3285
Idexx Laboratories
IDXX
$44.9B
| $1.73M | ﹤0.01% |
3,153
+2,700
| +596% | +$1.42M |
|
|
AMED
3286
CALL
DELISTED
Amedisys
AMED
| $1.72M | ﹤0.01% |
10,000
-1,500
| -13% | -$224K |
|
3287
Hackett Group
HCKT
$281M
| $1.72M | ﹤0.01% |
74,697
-45,725
| -38% | -$931K |
|
3288
Orthofix Medical
OFIX
$492M
| $1.72M | ﹤0.01% |
52,696
-11,074
| -17% | -$356K |
|
|
WIRE
3289
PUT
DELISTED
Encore Wire Corp
WIRE
| $1.72M | ﹤0.01% |
+15,100
| New | +$1.81M |
|
3290
Amcor
AMCR
$21.2B
| $1.72M | ﹤0.01% |
30,386
-71,649
| -70% | -$4.18M |
|
3291
PUT
Kroger
KR
$36.7B
| $1.72M | ﹤0.01% |
+30,000
| New | +$1.49M |
|
3292
CALL
UDR
UDR
$12.8B
| $1.72M | ﹤0.01% |
+30,000
| New | +$1.7M |
|
3293
Primoris Services
PRIM
$4.06B
| $1.72M | ﹤0.01% |
72,084
-5,381
| -7% | -$139K |
|
|
BCOV
3294
DELISTED
Brightcove, Inc.
BCOV
| $1.72M | ﹤0.01% |
220,019
+15,972
| +8% | +$136K |
|
|
NEE.PRP
3295
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $1.71M | ﹤0.01% |
32,706
-17,632
| -35% | -$900K |
|
|
IRBT
3296
PUT
DELISTED
iRobot
IRBT
| $1.71M | ﹤0.01% |
27,000
-30,000
| -53% | -$1.9M |
|
|
SMLR
3297
DELISTED
Semler Scientific
SMLR
| $1.71M | ﹤0.01% |
+34,519
| New | +$2.31M |
|
3298
Rocket Companies
RKT
$38.8B
| $1.71M | ﹤0.01% |
153,771
-14,718
| -9% | -$182K |
|
|
TSIB
3299
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
| $1.71M | ﹤0.01% |
174,385
-161,486
| -48% | -$1.57M |
|
3300
PUT
Medifast
MED
$107M
| $1.71M | ﹤0.01% |
10,000
-21,300
| -68% | -$4.02M |
|
Similar funds
D.E. Shaw & Co's Q1 2022 Portfolio in Review
As of Q1 2022, D.E. Shaw & Co held 6,280 positions worth $107B, down 11% from $121B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
D.E. Shaw & Co withdrew a net $14.2B in Q1 2022, closing 805 positions and reducing 2,078 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $1.02B position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in Cenovus Energy worth $141M.
- D.E. Shaw & Co's largest Q1 2022 buy was Cenovus Energy: 8,428,527 shares worth $141M.
- D.E. Shaw & Co added most to Starbucks in Q1 2022, an estimated $384M increase.
- D.E. Shaw & Co's biggest Q1 2022 reduction was Netflix, cutting an estimated $461M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2022, selling an estimated $1.02B.
- D.E. Shaw & Co's ten largest holdings make up 9.3% of its $107B portfolio in Q1 2022.
- D.E. Shaw & Co opened 934 new positions and closed 805 in Q1 2022.
- D.E. Shaw & Co's portfolio value fell 11% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.